The major EGFR downstream target, the Ras/RAF/MEK/ERK (MAPK) signaling pathway, plays a crucial role in the survival, growth and proliferation of cancer cells, and its hyperactivation is responsible for over 40% of human cancer cases [46,89]. Here, EGFR is linked to cancer.